NAPRA Position Available
NAPRA is currently seeking a candidate to fill the position of Manager, Professional and Regulatory Affairs - Maternity Leave Replacement (4-5 days/week)
For a complete position description, please see the link below.
Please submit a cover letter and résumé by e-mail to KathyBedard@McConnellHRC.Com by August 10, 2016.
Manager, Professional and Regulatory Affairs - Maternity Leave Replacement (4-5 days/week)
NDSAC - Nomination sought for Committee membership
The National Drug Scheduling Advisory Committee (NDSAC) is soliciting nominations to fill a membership vacancy
Pharmacy Technician Bridging Education Program-Course and PLAR exam schedules
Please note, this section will be updated periodically as the information becomes available.
Reminder: Courses and PLAR exams available in both English and French
NOTE: Selkirk College registration deadline for all English and French courses beginning in September 2016 is August 25, 2016
Rappel : Les cours et les examens ERA sont offerts en français et en anglais
REMARQUE : La date limite pour l’inscription aux cours (anglais et français) débutant en septembre 2016 au collège Selkirk est le 25 août 2016
Registration deadlines for all institutions are available on the Course and PLAR Schedules page.
Registration for all courses is conducted directly with the educational institution offering the program.
NDSAC Meeting of September 12-13, 2016
The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for September 12-13, 2016 is cancelled.
The next meeting of the Committee is scheduled for December 5-6, 2016. The deadline to receive submissions for a drug scheduling application for this meeting is by end of day Thursday, October 6, 2016.
Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring Systems that may pose serious health risks
As Health Canada previously communicated, Alere Inc. is withdrawing the Alere INRatio® and INRatio® 2 Prothrombin Time (PT) Monitoring Systems (professional use and patient self-test) devices from the Canadian market. These devices measure blood clotting time in patients requiring warfarin and other oral blood-thinning medicines. There is a risk that the Alere devices provide an inaccurate low reading.
Health Canada Information Update
Two unauthorized products “B-Hard on Demand” and “Wonderblue” seized at Désirs et Plaisirs in St-Jérôme, QC
may pose serious health risks
Health Canada has seized two unauthorized products being promoted as natural health products for sexual enhancement from Désirs et Plaisirs in St-Jérôme, Quebec. These products were found to contain undeclared prescription drug substances and other drug substances that may pose serious risks to the health of Canadians.
Health Canada Advisory
Health Product Risk Communication
Important Safety Information on Inferior Vena Cava (IVC) Filters and Risk of Serious Complications
Serious complications have been reported in patients implanted with an IVC filter, including caval perforation, caval thrombosis, filter fracture and fragment embolization, intracardiac migration, cardiac perforation, cardiac tamponade, and death. Many of these complications occurred with long-term (greater than 30 days) filter implantation.
Health Canada Health Product Risk Communication